Consolidated Balance Sheets - USD ($)	Jun. 30, 2020	Jun. 30, 2019
CURRENT ASSETS
Cash	$ 15,282	$ 27,453
Prepaid expenses and other assets	13,361	9,470
Tax refunds receivable	3,317	6,852
Accounts receivable, net	9,858	29,525
Note receivable, related party	6,878	5,671
Total Current Assets	48,696	78,971
Property and Equipment, Net	1,922	0
Operating lease right-of-use asset	74,710	0
TOTAL ASSETS	125,328	78,971
LIABILITIES
Accounts payable and accrued expenses	119,246	164,145
Accrued interest - related party	42,359	28,458
Notes payable - related party	618,568	478,357
Current portion of operating lease liability	11,312	0
Total Current Liabilities	791,485	670,960
Operating lease liability, net of current portion	63,721	0
Total Liabilities	855,206	670,960
COMMITMENTS AND CONTINGENCIES	0	0
STOCKHOLDERS' DEFICIT
Preferred stock, no par value; 10,000,000 shares authorized, -0- shares issued and outstanding	0	0
Common stock, no par value; 250,000,000 shares authorized 203,355,598 and 199,295,503 shares issued and 203,301,842 and 199,241,747 shares outstanding respectively	33,027,676	32,967,499
Additional paid-in capital	4,513,328	4,513,328
Treasury stock, at cost	(19,387)	(19,387)
Accumulated other comprehensive income	91,907	91,447
Accumulated deficit	(37,696,425)	(37,503,684)
Total Sangui Biotech International, Inc's stockholders' defict	(82,901)	49,203
Non-controlling interest	(646,977)	(641,192)
Total Stockholders' Deficit	(729,878)	(591,989)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 125,328	$ 78,971